Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
179 Leser
Artikel bewerten:
(1)

Axon Ivy is Positioned as the Leader in the 2024 SPARK Matrix Intelligent Business Process Management Suites (iBPMS) by QKS Group

  • The QKS Group SPARK Matrix provides competitive analysis and ranking of the leading iBPMS vendors.
  • Axon Ivy with its comprehensive technology and customer experience management, has received strong ratings across the parameters of technology excellence and customer impact.

MIDDLETON, Mass., Oct. 31, 2024 /PRNewswire/ -- QKS Group has named Axon Ivy as a Leader in their 2024 SPARK Matrix analysis of the Intelligent Business Process Management Suites (iBPMS) market.

QKS_Group_Logo

The QKS Group SPARK Matrix evaluates vendors based on technology excellence and customer impact. It offers an in-depth analysis of global market dynamics, major trends, vendor landscapes, and competitive positioning. By providing a competitive analysis and ranking of leading technology vendors, the SPARK Matrix delivers strategic insights that help users access provider capabilities, differentiate competitively, and understand market positions.

Axon Ivy is recognized as a leader in the 2024 SPARK Matrix: Intelligent Business Process Management Suites (iBPMS) for its robust capabilities that allow organizations to automate and integrate their existing systems while orchestrating people, data, systems, and other platforms, such as AI and RPA, on one unified platform. The open architecture of Axon Ivy iBPMS is designed for flexibility and extensibility, ensuring that the platform can easily integrate with third-party systems.

QKS Group defines Intelligent Business Process Management Suites as a cloud-based integrated group of technologies that automate business processes through low-code/no-code tools thus connecting people, systems, machines, and the Internet of Things (IoT). Intelligent Business Process Management Suites (iBPMS) help organizations perform end-to-end business process management by incorporating real-time decision-making, complex event processing, business rules engine, and artificial intelligence. In addition, iBPMS offers interactive social media capabilities to encourage real-time ad-hoc interactions, collaboration, and sharing of knowledge between users, IT teams, as well as developers using 'cross-channel mobility enabled' devices. The model-driven approach of iBPMS enables organizations to map, monitor, manage, and control complex business processes and optimize organizational performance to provide a sustainable competitive advantage enabling the creation of an efficient, dynamic, and agile platform.

"Axon Ivy's Intelligent Business Process Management Suite (iBPMS) redefines enterprise process automation. The platform caters to users across all skill levels, offering a seamless development spectrum from no-code to full-stack capabilities. Its advanced user dialog concept, based on the model-view-controller pattern, ensures an intuitive interface design, while its open architecture facilitates extensive third-party integrations and custom extensions. Additionally, the intelligent document handling capability, powered by DocFactory, provides comprehensive document management," said Kunal Pakhale, Senior Analyst at QKS Group.

Kunal further adds, "Axon Ivy's innovative approach to iBPMS sets a new standard in the market, especially the platform's intuitive user-centric design, robust Adaptive Case Management (ACM), and orchestration capabilities". By enabling organizations to rapidly digitize both simple processes and complex, business-critical applications, Axon Ivy's iBPMS stands out in today's dynamic digital landscape for its flexibility, user-friendliness, and ability to meet diverse business needs.

"Axon Ivy is proud to be recognized as a SPARK Leader in the 2024 SPARK Matrix for Intelligent Business Process Management Suites," said Rolf Gebhard Stephan, CEO of Axon Ivy. "This recognition validates our strategy of delivering innovative yet reliable technology while maintaining our focus on maximum customer satisfaction."

The Intelligent Business Process Management Suites (iBPMS) market is experiencing significant growth as organizations worldwide embrace digital transformation as a strategic imperative. This reflects the increasing need for sophisticated process automation and intelligent workflow automation solutions. As organizations continue to lean on providing end-to-end automation solutions, iBPMS is crucial for enhancing efficiency, reducing expenses, and improving overall operational excellence. Over the next decade, iBPMS will likely evolve through several key growth factors including the integration of advanced AI capabilities for enhanced decision-making and predictive analytics, low-code platforms for democratizing process automation across organizations, Cloud-native solutions for facilitating seamless scaling and integration, and process mining solutions for continuous process improvements. As regulatory requirements grow more complex, automated compliance features will become essential. Furthermore, the convergence of iBPMS with adjacent automation technologies will drive efficiency, supporting an increasingly distributed workforce while maintaining robust security and governance frameworks.

Additional Resources:

  • For more information about Axon Ivy
  • SPARK Matrix:Intelligent Business Process Management Suites, Q4 2024

About Axon Ivy:
Axon Ivy is a pioneering process automation and BPM software provider, dedicated to solving one of today's most critical business challenges: inefficient processes. Headquartered in Switzerland with a global presence, the company combines nearly three decades of expertise with innovative technology that bridges simple workflows and sophisticated business-critical applications. Through its AI-enhanced platform, optimized for both business users and developers, Axon Ivy enables organizations to transform their operations, ensure compliance, and deliver exceptional customer experiences. Operating as an independent subsidiary of the Ricoh Group since 2022, Axon Ivy leverages deep industry knowledge and an extensive partner network to deliver future-proof solutions across all sectors. For more information, please visit https://www.axonivy.com/ .

Media Contact:

Alexandra Witzke-Ng
Head of Marketing / Axon Ivy AG
E-Mail: Alexandra.Witzke-Ng@axonivy.com

About QKS Group:

QKS Group is a global advisory and consulting firm focused on helping clients achieve business transformation goals with Strategic Business and Growth advisory services. At QKS Group, our vision is to become an integral part of our client's business as a strategic knowledge partner. Our research and consulting deliverables are designed to provide comprehensive information and strategic insights for helping clients formulate growth strategies to survive and thrive in ever-changing business environments.

For more available research, please visit https://qksgroup.com/

Media ContactQKS Group:

Shraddha Roy
PR & Media Relations
QKS Group
Regus Business Center
35 Village Road, Suite 100,
Middleton Massachusetts 01949
United States
Email: shraddha.r@qksgroup.com
Press Release Source: https://qksgroup.com/newsroom/axon-ivy-is-positioned-as-the-leader-in-the-2024-spark-matrixtm-intelligent-business-process-management-suites-ibpms-by-qks-group-849
Follow us on LinkedIn: https://www.linkedin.com/company/qksgroup

Logo: https://mma.prnewswire.com/media/2501519/QKS_Group_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/axon-ivy-is-positioned-as-the-leader-in-the-2024-spark-matrix-intelligent-business-process-management-suites-ibpms-by-qks-group-302292780.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.